Sumalinog, Mary Joy .
HRN: 26-59-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2025
CEFUROXIME 500MG (TAB)
04/05/2025
04/11/2025
PO
500mg
BID
Nsvd Wbc 19
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes